NUTEX HEALTH INC (NUTX) Stock Overview
NASDAQ:NUTX - US67079U3068 - Common Stock
NUTX Key Statistics, Chart & Performance
The current stock price of NUTX is 83.79 USD. In the past month the price decreased by -0.25%. In the past year, price increased by 291.73%.
NUTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
| CI | THE CIGNA GROUP | 10.71 | 80.31B | ||
| LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.6 | 15.08B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
| DVA | DAVITA INC | 14.22 | 9.85B | ||
| HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
| CHE | CHEMED CORP | 20.47 | 6.67B | ||
| RDNT | RADNET INC | 199.33 | 5.52B | ||
| OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B |
Related stock screener links
About NUTX
Company Profile
Nutex Health, Inc. is a technology-enabled healthcare service. The company is headquartered in Houston, Texas and currently employs 800 full-time employees. The company went IPO on 2011-03-18. The firm operates through three segments: The Hospital division, The Population Health Management (PHM) division and The Real Estate division. The Hospital division develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs) providing comprehensive and high-quality 24/7 care. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). The Real Estate division owns the land and hospital buildings which are leased to its hospital entities. The firm also provides limited services to one health maintenance organization (HMO) and two other IPAs in Southern and Northern California. The firm's cloud-based technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers.
Company Info
NUTEX HEALTH INC
6030 S. Rice Ave., Suite C
Houston TEXAS US
Employees: 830
Phone: 17136600557
NUTEX HEALTH INC / NUTX FAQ
What is the stock price of NUTEX HEALTH INC today?
The current stock price of NUTX is 83.79 USD. The price decreased by -5.2% in the last trading session.
What is the ticker symbol for NUTEX HEALTH INC stock?
The exchange symbol of NUTEX HEALTH INC is NUTX and it is listed on the Nasdaq exchange.
On which exchange is NUTX stock listed?
NUTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NUTEX HEALTH INC stock?
9 analysts have analysed NUTX and the average price target is 253.3 USD. This implies a price increase of 202.3% is expected in the next year compared to the current price of 83.79. Check the NUTEX HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NUTEX HEALTH INC worth?
NUTEX HEALTH INC (NUTX) has a market capitalization of 465.87M USD. This makes NUTX a Small Cap stock.
How many employees does NUTEX HEALTH INC have?
NUTEX HEALTH INC (NUTX) currently has 830 employees.
What are the support and resistance levels for NUTEX HEALTH INC (NUTX) stock?
NUTEX HEALTH INC (NUTX) has a support level at 83.78 and a resistance level at 96.18. Check the full technical report for a detailed analysis of NUTX support and resistance levels.
Is NUTEX HEALTH INC (NUTX) expected to grow?
The Revenue of NUTEX HEALTH INC (NUTX) is expected to grow by 144.93% in the next year. Check the estimates tab for more information on the NUTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NUTEX HEALTH INC (NUTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NUTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NUTX, evaluating the profitability, health, valuation and growth aspects
- NUTEX HEALTH INC (NUTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NUTEX HEALTH INC (NUTX) Sales and EPS estimates to see what analysts future expectations are.
- NUTEX HEALTH INC (NUTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NUTEX HEALTH INC (NUTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- NUTEX HEALTH INC (NUTX) Stock Chart to make your own analysis
- NUTEX HEALTH INC (NUTX) Latest news and press-releases to stay up to date.
Does NUTEX HEALTH INC (NUTX) stock pay dividends?
NUTX does not pay a dividend.
When does NUTEX HEALTH INC (NUTX) report earnings?
NUTEX HEALTH INC (NUTX) will report earnings on 2025-11-05.
What is the Price/Earnings (PE) ratio of NUTEX HEALTH INC (NUTX)?
The PE ratio for NUTEX HEALTH INC (NUTX) is 7.05. This is based on the reported non-GAAP earnings per share of 11.89 and the current share price of 83.79 USD. Check the full fundamental report for a full analysis of the valuation metrics for NUTX.
What is the Short Interest ratio of NUTEX HEALTH INC (NUTX) stock?
The outstanding short interest for NUTEX HEALTH INC (NUTX) is 25.35% of its float. Check the ownership tab for more information on the NUTX short interest.
NUTX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to NUTX. When comparing the yearly performance of all stocks, NUTX is one of the better performing stocks in the market, outperforming 97.36% of all stocks.
NUTX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NUTX. Both the profitability and the financial health of NUTX get a neutral evaluation. Nothing too spectacular is happening here.
NUTX Financial Highlights
Over the last trailing twelve months NUTX reported a non-GAAP Earnings per Share(EPS) of 11.89. The EPS increased by 430.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.76% | ||
| ROA | 8.82% | ||
| ROE | 34.08% | ||
| Debt/Equity | 1.46 |
NUTX Forecast & Estimates
9 analysts have analysed NUTX and the average price target is 253.3 USD. This implies a price increase of 202.3% is expected in the next year compared to the current price of 83.79.
For the next year, analysts expect an EPS growth of -9.22% and a revenue growth 144.93% for NUTX